Cite
HARVARD Citation
Steger, G. et al. (n.d.). 1857 Final results of a phase II study evaluating oral vinorelbine as a single-agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial). European journal of cancer. pp. S284-. [Online].